Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221702

Medchemexpress LLC Enbezotinib (TPX-0046) | 2359649-81-1 | 99.5% | 424.43 g/mol | C21H21FN6O3 | 5 MG
SDP

Catalog No. 5000221702
Encompass_Preferred

Enbezotinib is a small-molecule RET kinase inhibitor for preclinical cancer research. It inhibits RET autophosphorylation, exhibits potent in vitro activity against RET-driven cells, and has demonstrated tumor size reduction in animal models. Supplied as a high-purity solid with solution formats available for laboratory use.

  • Inhibits RET autophosphorylation.
  • Potent in vitro activity against RET-driven cells.
  • Demonstrated tumor growth reduction in animal models.
  • High-purity solid and solution formats available.
  • Intended for research use only.

Catalog No. 50-002-21702 Supplier Medchemexpress LLC Supplier No. HY1455655MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Enbezotinib is a small-molecule RET kinase inhibitor for preclinical cancer research. It inhibits RET autophosphorylation, exhibits potent in vitro activity against RET-driven cells, and has demonstrated tumor size reduction in animal models. Supplied as a high-purity solid with solution formats available for laboratory use.

  • Inhibits RET autophosphorylation.
  • Potent in vitro activity against RET-driven cells.
  • Demonstrated tumor growth reduction in animal models.
  • High-purity solid and solution formats available.
  • Intended for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.